Clinical Trial Update: CD4CAR for CD4+ Leukemia and Lymphoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating CD4CAR as a CAR-T therapy for T-cell lymphoma and T-cell leukemia, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• T-cell Leukemia
• T-cell Lymphoma

Drugs mentioned

• CD4CAR

Snippet

Sponsor: Huda Salman | Conditions: T-cell Lymphoma, T-cell Leukemia | Phase 1 | Status: RECRUITING